U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
bleselumab [INN]
Preferred Name English
BLESELUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
Bleselumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CD40 (TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5, TNFRSF5)), HUMAN MONOCLONAL ANTIBODY
Common Name English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CD40 (TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5, TNFRSF5)), HUMAN MONOCLONAL ANTIBODY GAMMA4 HEAVY CHAIN (1-448) (HOMO SAPIENS VH (IGHV4- 39*01 (92.90%) -(IGHD)-IGHJ5*01) (10.7.13) (1-121) - IGHG4*01
Systematic Name English
IMMUNOGLOBULIN G4, ANTI-(HUMAN CD40 ANTIGEN) (HUMAN MONOCLONAL ASKP1240 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ASKP1240 LIGHT CHAIN, DIMER
Common Name English
ASKP1240
Code English
ASKP-1240
Code English
BLESELUMAB [USAN]
Common Name English
Code System Code Type Description
CAS
1453067-91-8
Created by admin on Mon Mar 31 23:24:11 GMT 2025 , Edited by admin on Mon Mar 31 23:24:11 GMT 2025
PRIMARY
WIKIPEDIA
Bleselumab
Created by admin on Mon Mar 31 23:24:11 GMT 2025 , Edited by admin on Mon Mar 31 23:24:11 GMT 2025
PRIMARY
NCI_THESAURUS
C171700
Created by admin on Mon Mar 31 23:24:11 GMT 2025 , Edited by admin on Mon Mar 31 23:24:11 GMT 2025
PRIMARY
USAN
EF-27
Created by admin on Mon Mar 31 23:24:11 GMT 2025 , Edited by admin on Mon Mar 31 23:24:11 GMT 2025
PRIMARY
FDA UNII
AS3AZ5R46K
Created by admin on Mon Mar 31 23:24:11 GMT 2025 , Edited by admin on Mon Mar 31 23:24:11 GMT 2025
PRIMARY
INN
10114
Created by admin on Mon Mar 31 23:24:11 GMT 2025 , Edited by admin on Mon Mar 31 23:24:11 GMT 2025
PRIMARY
SMS_ID
100000171741
Created by admin on Mon Mar 31 23:24:11 GMT 2025 , Edited by admin on Mon Mar 31 23:24:11 GMT 2025
PRIMARY
DRUG BANK
DB15253
Created by admin on Mon Mar 31 23:24:11 GMT 2025 , Edited by admin on Mon Mar 31 23:24:11 GMT 2025
PRIMARY
ACTIVE MOIETY
BLESELUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966